Related Experiment Video
Updated: Aug 17, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Pulmonary hypertension. Anatomic and physiologic correlates
Abstract:
The types of pulmonary arterial hypertension described here all focus attention on the changes produced in the lung's microcirculation, particularly the precapillary unit. Although one senses intuitively that obliteration of resistance arteries is an effective cause of hypertension, we emphasize that cell metaplasia and adaptation by structural remodeling of the precapillary arterial wall is also effective in reducing the vascular bed. A question often asked is whether "pruning" is the cause of the hypertension . . . perhaps an inappropriate question. While the reduced cross-sectional area of the vascular bed is the basis for the rise in pulmonary vascular resistance and for its severity, the real question is what is the cause of the "pruning." Hypoxia, monocrotaline, and high flow each causes pulmonary artery hypertension--and pruning--but with differences in cell adaptation, timing, and severity that indicate different pathogenetic mechanisms and pathways. It is paradoxical that hypoxia, whose lesions are more reversible, produces a more severe hypertension and faster than the others. While the pathophysiologic aspects are important to clinical diagnosis and management, it is analysis of cause and pathways of pathogenesis that will give the keys to prevention and cure of the disease.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction

